Close

Tag: Biopharma Businesses

Telangana Aims to Emerge as India’s Life Sciences Innovation Capital with $25B Investment Target by 2030

Strengthening Domestic API Depth and Reducing Import Reliance Key to Global Competitiveness Reaching $300B Valuation Demands Rapid Innovation, Biologics Scale, and Sustainable Quality...

CPHI & PMEC Shenzhen 2026 Attracts Unprecedented International Interest as Demand for AI-Driven Innovation Grows

CPHI & PMEC Shenzhen 2026 is set to welcome its most international audience to date, reflecting growing global interest in South China's rapidly evolving pharmaceutical...

CPHI Launches New Sustainability Summit as Pharma Faces Growing Pressure to Deliver Sustainability Goals

CPHI has announced the launch of the CPHI Sustainability Summit, a new two-day event dedicated to advancing sustainability across the pharmaceutical value chain. Taking place...

Study Identifies Tiered Manufacturing in Global Pharmaceutical Markets

A new research project from the Johns Hopkins Bloomberg School of Public Health has identified a pharmaceutical industry practice that could be a significant...

Sanofi Secures Global Rights to Rovadicitinib in $1.53B Deal

Sanofi has committed up to $1.53 billion to obtain global rights to a novel therapy from Sino Biopharmaceutical, adding a first-in-class JAK/ROCK inhibitor to...

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to head deeper into the KRAS space by way of securing the right when it comes...

Bora – Corealis Collaborate for Oral Solid Dose Development

Bora Pharmaceuticals Co. Ltd., which is a global leader when it comes to pharmaceutical manufacturing, along with a leading early-phase Contract Development Manufacturing Organization...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »